Search Results - "Sweet, A"

Auditory dysfunction in schizophrenia: integrating clinical and basic features by Javitt, Daniel C., Sweet, Robert A.

“…Key Points Individuals with schizophrenia show deficits in auditory sensory processing that represent a core feature of the disorder. At the behavioural level,…”
Get full text

Genetic risk for schizophrenia and psychosis in Alzheimer disease by DeMichele-Sweet, M A A, Weamer, E A, Klei, L, Vrana, D T, Hollingshead, D J, Seltman, H J, Sims, R, Foroud, T, Hernandez, I, Moreno-Grau, S, Tárraga, L, Boada, M, Ruiz, A, Williams, J, Mayeux, R, Lopez, O L, Sibille, E L, Kamboh, M I, Devlin, B, Sweet, R A

“…Psychotic symptoms, defined as the occurrence of delusions or hallucinations, are frequent in Alzheimer disease (AD), affecting ~40 to 60% of individuals with…”
Get full text

The glutamate hypothesis of schizophrenia: evidence from human brain tissue studies by Hu, Wei, MacDonald, Matthew L., Elswick, Daniel E., Sweet, Robert A.

“…A number of studies have indicated that antagonists of the N‐methyl‐d‐aspartate subtypes of glutamate receptors can cause schizophrenia‐like symptoms in…”
Get full text

Psychosis in Alzheimer’s Disease by Murray, Patrick S, Kumar, Sanjeev, DeMichele-Sweet, Mary Ann A, Sweet, Robert A

“…Psychotic symptoms, delusions and hallucinations, occur in approximately 50% of individuals with Alzheimer’s disease (AD) (AD with psychosis [AD + P])…”
Get full text

Version 3 of the National Alzheimer’s Coordinating Center’s Uniform Data Set by Besser, Lilah, Kukull, Walter, Knopman, David S, Chui, Helena, Galasko, Douglas, Weintraub, Sandra, Jicha, Gregory, Carlsson, Cynthia, Burns, Jeffrey, Quinn, Joseph, Sweet, Robert A, Rascovsky, Katya, Teylan, Merilee, Beekly, Duane, Thomas, George, Bollenbeck, Mark, Monsell, Sarah, Mock, Charles, Zhou, Xiao Hua, Thomas, Nicole, Robichaud, Elizabeth, Dean, Margaret, Hubbard, Janene, Jacka, Mary, Schwabe-Fry, Kristen, Wu, Joylee, Phelps, Creighton, Morris, John C

“…INTRODUCTION:In 2015, the US Alzheimer’s Disease Centers (ADC) implemented Version 3 of the Uniform Data Set (UDS). This paper describes the history of Version…”
Get full text

Schizophrenia from a neural circuitry perspective: advancing toward rational pharmacological therapies by Lewis, David A, Sweet, Robert A

“…Schizophrenia is a severe disorder that disrupts the function of multiple brain systems, resulting in impaired social and occupational functioning. The…”
Get full text

Restoration of reaching and grasping movements through brain-controlled muscle stimulation in a person with tetraplegia: a proof-of-concept demonstration by Ajiboye, A Bolu, Dr, Willett, Francis R, BS, Young, Daniel R, BS, Memberg, William D, MS, Murphy, Brian A, PhD, Miller, Jonathan P, MD, Walter, Benjamin L, MD, Sweet, Jennifer A, MD, Hoyen, Harry A, MD, Keith, Michael W, MD, Peckham, P Hunter, Prof, Simeral, John D, PhD, Donoghue, John P, Prof, Hochberg, Leigh R, Prof, Kirsch, Robert F, Prof

“…Summary Background People with chronic tetraplegia, due to high-cervical spinal cord injury, can regain limb movements through coordinated electrical…”
Get full text

Effects of Vitamin D Use on Outcomes of Psychotic Symptoms in Alzheimer Disease Patients by Wang, Lirong, Ying, Jian, Fan, Peihao, Weamer, Elise A., DeMichele-Sweet, Mary Ann A., Lopez, Oscar L., Kofler, Julia K., Sweet, Robert A.

“…•Vitamin D was used more often in patients of Alzheimer's disease without psychosis symptoms than in patients of Alzheimer's disease with psychosis…”
Get full text

Terminal type-specific cannabinoid CB1 receptor alterations in patients with schizophrenia: A pilot study by Chou, Shinnyi, Fish, Kenneth N, Lewis, David A, Sweet, Robert A

“…Individuals with schizophrenia are at elevated genetic risks for comorbid cannabis use, and often experience exacerbations of cognitive and psychotic symptoms…”
Get full text

Genetics of psychosis of Alzheimer disease by Shah, Chintan, DeMichele‐Sweet, Mary Ann A., Sweet, Robert A.

“…Psychotic symptoms, comprised of delusions and hallucinations, occur in about half of individuals with Alzheimer disease (AD with psychosis, AD+P). These…”
Get full text

More than a marker: potential pathogenic functions of MAP2 by DeGiosio, Rebecca A., Grubisha, Melanie J., MacDonald, Matthew L., McKinney, Brandon C., Camacho, Carlos J., Sweet, Robert A.

“…Microtubule-associated protein 2 (MAP2) is the predominant cytoskeletal regulator within neuronal dendrites, abundant and specific enough to serve as a robust…”
Get full text

Selective Loss of Smaller Spines in Schizophrenia by MacDonald, Matthew L, Alhassan, Jamil, Newman, Jason T, Richard, Michelle, Gu, Hong, Kelly, Ryan M, Sampson, Alan R, Fish, Kenneth N, Penzes, Peter, Wills, Zachary P, Lewis, David A, Sweet, Robert A

“…Objective:Decreased density of dendritic spines in adult schizophrenia subjects has been hypothesized to result from increased pruning of excess synapses in…”
Get full text

Psychosis in Alzheimer’s Disease by Ballard, Clive, Kales, Helen C., Lyketsos, Constantine, Aarsland, Dag, Creese, Byron, Mills, Roger, Williams, Hilde, Sweet, Robert A.

“…Purpose of Review To review the incidence, treatment and genetics of psychosis in people with mild cognitive impairment (MCI) and Alzheimer’s disease (AD)…”
Get full text

Cell type specific cannabinoid CB1 receptor distribution across the human and non-human primate cortex by Chou, Shinnyi, Ranganath, Tejis, Fish, Kenneth N., Lewis, David A., Sweet, Robert A.

“…Alterations in cannabinoid CB1 receptor (CB1R) are implicated in various psychiatric disorders. CB1R participates in both depolarization induced suppression of…”
Get full text

Effect of Alzheimer’s Disease Risk Genes on Trajectories of Cognitive Function in the Cardiovascular Health Study by Sweet, Robert A., Seltman, Howard, Emanuel, James E., Lopez, Oscar L., Becker, James T., Bis, Joshua C., Weamer, Elise A., DeMichele-Sweet, Mary Ann A., Kuller, Lewis H.

“…ObjectiveThe trajectory of cognitive decline in patients with late-onset Alzheimer’s disease varies widely. Genetic variations in CLU, PICALM, and CR1 are…”
Get full text

Polytrauma and High-energy Injury Mechanisms are Associated with Worse Patient-reported Outcomes After Distal Radius Fractures by van der Vliet, Q M J, Sweet, A A R, Bhashyam, A R, Ferree, S, van Heijl, M, Houwert, R M, Leenen, L P H, Hietbrink, F

“…Patient-reported outcomes (PROs) are increasingly relevant when evaluating the treatment of orthopaedic injuries. Little is known about how PROs may vary in…”
Get full text

Psychosis in Alzheimer disease — mechanisms, genetics and therapeutic opportunities by Ismail, Zahinoor, Creese, Byron, Aarsland, Dag, Kales, Helen C., Lyketsos, Constantine G., Sweet, Robert A., Ballard, Clive

“…Psychosis is a common and distressing symptom in people with Alzheimer disease, and few safe and effective treatments are available. However, new approaches to…”
Get full text

Enhanced production of 60Fe in massive stars by Spyrou, A., Richman, D., Couture, A., Fields, C. E., Liddick, S. N., Childers, K., Crider, B. P., DeYoung, P. A., Dombos, A. C., Gastis, P., Guttormsen, M., Hermansen, K., Larsen, A. C., Lewis, R., Lyons, S., Midtbø, J. E., Mosby, S., Muecher, D., Naqvi, F., Palmisano-Kyle, A., Perdikakis, G., Prokop, C., Schatz, H., Smith, M. K., Sumithrarachchi, C., Sweet, A.

“…Massive stars are a major source of chemical elements in the cosmos, ejecting freshly produced nuclei through winds and core-collapse supernova explosions into…”
Get full text

Genome-wide association identifies the first risk loci for psychosis in Alzheimer disease by DeMichele-Sweet, Mary Ann A., Klei, Lambertus, Creese, Byron, Harwood, Janet C., Weamer, Elise A., McClain, Lora, Sims, Rebecca, Hernandez, Isabel, Moreno-Grau, Sonia, Tárraga, Lluís, Boada, Mercè, Alarcón-Martín, Emilio, Valero, Sergi, Liu, Yushi, Hooli, Basavaraj, Aarsland, Dag, Selbaek, Geir, Bergh, Sverre, Rongve, Arvid, Saltvedt, Ingvild, Skjellegrind, Håvard K., Engdahl, Bo, Stordal, Eystein, Andreassen, Ole A., Djurovic, Srdjan, Athanasiu, Lavinia, Seripa, Davide, Borroni, Barbara, Albani, Diego, Forloni, Gianluigi, Mecocci, Patrizia, Serretti, Alessandro, De Ronchi, Diana, Politis, Antonis, Williams, Julie, Mayeux, Richard, Foroud, Tatiana, Ruiz, Agustin, Ballard, Clive, Holmans, Peter, Lopez, Oscar L., Kamboh, M. Ilyas, Devlin, Bernie, Sweet, Robert A.

“…Psychotic symptoms, defined as the occurrence of delusions or hallucinations, are frequent in Alzheimer disease (AD with psychosis, AD + P). AD + P affects…”
Get full text

Developmental malformations resulting from high-dose maternal tamoxifen exposure in the mouse by Sun, Miranda R, Steward, Austin C, Sweet, Emma A, Martin, Alexander A, Lipinski, Robert J

“…Tamoxifen is an estrogen receptor (ER) ligand with widespread use in clinical and basic research settings. Beyond its application in treating ER-positive…”
Get full text